Manuscript - 1 February 2024 Novel technique for preclinical assessment of targeted therapies to inhibit both primary and metastatic non-small cell lung cancer
Manuscript - 1 February 2024 BxPC-3: Evaluating responses to standard therapeutic agents in subcutaneous mouse model of human pancreatic cancer
Manuscript - 1 December 2016 4T1-luc2: An orthotopic mammary cancer model to support novel immuno-oncology drug discovery
Manuscript - 1 August 2022 Exploring orthotopic glioblastoma models to treat tumors and strengthen immune responses in the brain
Manuscript - 1 August 2022 Plate-based 3D culture assays that mimic the tumor microenvironment and predict in vivo responses
Manuscript - 1 July 2018 Absolute counts by flow cytometry — maximize the accuracy of your immunophenotypic data interpretation
Manuscript - 1 February 2024 Novel technique for preclinical assessment of targeted therapies to inhibit both primary and metastatic non-small cell lung cancer
Manuscript - 1 February 2024 BxPC-3: Evaluating responses to standard therapeutic agents in subcutaneous mouse model of human pancreatic cancer
Manuscript - 1 August 2022 Exploring orthotopic glioblastoma models to treat tumors and strengthen immune responses in the brain
Manuscript - 1 August 2022 Plate-based 3D culture assays that mimic the tumor microenvironment and predict in vivo responses
Manuscript - 1 July 2018 Absolute counts by flow cytometry — maximize the accuracy of your immunophenotypic data interpretation
Manuscript - 1 December 2016 4T1-luc2: An orthotopic mammary cancer model to support novel immuno-oncology drug discovery